Ampath Chats

CRP vs. PCT: Which One to Choose and When?

Ampath Chats
CRP vs. PCT: Which One to Choose and When?
Read Document

PATHCHAT Edition No. 47
June 2018
Please contact your local Ampath pathologist for more information.

Compiled by: Dr. C. Kingsburgh

Introduction

🔹 Why Are Sepsis Biomarkers Important?

  • Sepsis diagnosis remains challenging due to delays in blood culture results and potential false positives/negatives.
  • Every hour delay in initiating appropriate therapy increases mortality by 7%.
  • Biomarkers such as CRP and PCT offer potential early detection tools.

Commonly Used Sepsis Biomarkers:

  1. C-reactive protein (CRP).
  2. Procalcitonin (PCT).

📌 CRP and PCT differ in their properties, sensitivity, specificity, and clinical applications.

What Are CRP & PCT?

🔹 C-Reactive Protein (CRP):

  • An acute phase protein synthesized in the liver in response to IL-6 during infections or inflammatory conditions.
  • Rises within 24–48 hours of infection and remains elevated for several days.
  • Non-specific marker of inflammation (not exclusive to bacterial infections).

🔹 Procalcitonin (PCT):

  • The precursor of calcitonin, normally synthesized by thyroid C-cells.
  • During bacterial infections, multiple tissues produce PCT, leading to a systemic rise in levels.
  • Rises much earlier (4–12 hours) compared to CRP (24–48 hours).
  • Highly specific to bacterial infections.

📌 PCT is less affected by viral infections and autoimmune diseases compared to CRP.

CRP vs. PCT: Which One to Choose?

Comparative Analysis of CRP & PCT in Bacterial Sepsis:

Sensitivity & Specificity:

  • PCT has higher sensitivity (77%) and specificity (79%) for bacterial septicaemia compared to CRP (75% and 67%).

Response Time:

  • PCT rises within 4–12 hours, CRP takes 24–48 hours.

Prognostic Value:

  • PCT correlates with bacterial load and severity of infection.
  • CRP does not correlate with severity.

Monitoring Treatment Response:

  • PCT has a half-life of 24–35 hours, making daily measurements clinically useful.
  • A 30–50% daily drop in PCT suggests effective infection control.
  • CRP has a longer half-life (~48 hours), limiting its utility in daily monitoring.

Guiding Antibiotic Therapy Duration:

  • Multiple ICU studies confirm that PCT-guided therapy reduces antibiotic duration and improves mortality.
  • In PCT-based protocols, antibiotics are stopped when PCT levels decrease by 80% from peak or fall below 0.5 ng/mL.

📌 PCT is a superior biomarker for early sepsis detection, prognosis, and treatment monitoring.

Indications for CRP & PCT

When to Use CRP:

  • To assess bacterial involvement in COPD exacerbations (Type II & III).
  • In the emergency department for uncertain community-acquired pneumonia (CAP) diagnosis.

When to Use PCT:

  • To differentiate bacterial sepsis from non-infectious systemic inflammatory response syndrome (SIRS).
  • To assess sepsis severity (prognostic marker).
  • To monitor response to therapy.
  • To guide antibiotic discontinuation in systemic bacterial infections.
  • To exclude bacterial CAP and acute COPD exacerbations if PCT <0.25 ng/mL.

📌 South African CAP guidelines state that CRP or PCT can be used in emergency settings where pneumonia diagnosis is uncertain.

Pros & Cons of CRP vs. PCT

🔹 Strengths of CRP:
Cheaper than PCT.
Not affected by renal disease or dialysis.
More likely to be elevated in fungal infections (e.g., invasive candidiasis).

🔹 Limitations of CRP:
🚨 Elevated by non-bacterial causes:

  • Trauma, surgery, autoimmune diseases.
  • Not useful for monitoring bacterial load.
  • Slower response time (peaks at 24–48 hours).

🔹 Strengths of PCT:
Higher sensitivity and specificity than CRP.
Rises quickly (4–12 hours) and clears faster (24–35 hours).
Excellent for monitoring sepsis progression.
Not elevated by viral infections, most autoimmune diseases, or transplant rejection.

🔹 Limitations of PCT:
🚨 Elevated by non-bacterial conditions:

  • Severe trauma, burns, pancreatitis, prolonged cardiogenic shock.
  • Certain autoimmune diseases (e.g., Kawasaki disease, Goodpasture’s syndrome).
    🚨 More expensive than CRP.

📌 PCT is a better biomarker for bacterial sepsis but is costly and may not be suitable for all clinical settings.

Conclusion

CRP and PCT are both useful sepsis biomarkers but have different applications.
PCT is superior for early diagnosis, severity assessment, and monitoring treatment response.
CRP is cheaper and useful for screening bacterial infections in conditions like COPD exacerbations.
PCT-guided antibiotic therapy has been proven to reduce antibiotic use and hospital stay.

📌 Choosing between CRP and PCT depends on the clinical context, cost considerations, and required diagnostic accuracy.